Skip to main content

Table 2 Selected clinical parameters in the group of patients with rheumatoid arthritis

From: Left ventricular myocardial strain assessed by cardiac magnetic resonance feature tracking in patients with rheumatoid arthritis

Duration of illness [years] 8.35 ± 6.56
C-reactive protein (CRP) [mg/l] 17.47 ± 17.23
Rheumatoid factor (RF) [IU/ml] 163.83 ± 329.98
Anti-cyclic citrullinated peptide (anti-CCP) [EU/ml] 333.69 ± 479.44
Seropositivity [n/%] 19 / 63.3
Disease activity index DAS28 6.48 ± 0.52
Collective assessment of health by the patient and the doctor (VAS) 82.50 ± 4.08
Neutrophil gelatinase-associated lipocalin (NGAL) [ng/ml] 12.79 ± 8.80
Steroids [n/%] 20/66.7
Methotrexate [n/%] 22/73.3
Other disease-modifying drugs [n/%] 12/40.0
Salazopyrin 1/3.3
Leflunomide 7/23.3
Cyclosporine 3/10.0
Chloroquine 1/3.3